Healthcare Professional Resources

Explore resources tailored to support your everyday practice.

CV Management Guidelines

Heart Failure Management: Key Updates

Learn why rapid sequencing and the “four pillars” approach are transforming care for patients with HFrEF and HFpEF.
 

2024 ESC Hypertension Guidelines

Simplified blood pressure thresholds and treatment strategies for better outcomes.

ESC Guidelines - Biomarkers in HF

Discover how biomarkers can guide heart failure treatment in this expert video featuring Dr. Hani Sabbour.
 

Heart Failure Management: Key Updates

An international modified Delphi consensus study captures expert perspectives on the diagnosis and management of HFpEF.

Consensus statement of Australian clinicians for the pharmacological management of heart failure

GDMT Implementation in Clinical Practice

Explore resources tailored to support your everyday practice.

Clinical Audit: Heart Failure Management for Primary Care

Assess how your prescribing aligns with best-practice care in this CPD-accredited audit of GDMT use in heart failure.  Sponsored by AstraZeneca.

Real World Evidence

Explore how Advara HeartCare’s Cardiology Group is transforming HFrEF treatment with real-world implementation of four-pillar therapy and SGLT2 inhibitors.

Inside the HFrEF Guideline Initiative

Highlights from Advara HeartCare’s nurse-led program, shared at CSANZ 2024, with reflections from Dr Leighton Kearney, A/Prof. David Eccleston and Racheal Watt.

Heart Failure Patient Identification, Screening & Diagnosis

DETECT Tools for Heart Failure

Access practical tools to support the identification and recall of patients with heart failure.

 

Understanding HFpEF vs HFrEF

Explore the crucial differences between the two common types of Heart Failure: HFpEF (Heart Failure with Preserved Ejection Fraction) and HFrEF (Heart Failure with Reduced Ejection Fraction).

Spotlight on Heart Failure Management: When should comprehensive therapies be initiated?

Dr. Javed Butler outlines his approach to ensure optimal initiation of comprehensive therapy for heart failure management.

Spotlight on Heart Failure with Reduced Ejection Fraction: Cardiologists’ Perspective

Dr Javed Butler gives his perspective on “stable” heart failure and the risk factors to be aware of when assessing patients.

Spotlight on Heart Failure: The Impact of Early Detection

Dr Javed Butler discusses his perspective on the factors that interfere with the early detection of heart failure and how to address these factors when assessing your patients.

Spotlight on Heart Failure: The Impact of Treatment Delay

Dr Javed Butler highlights the impact of treatment delay on patients with heart failure and how acting earlier can have positive outcomes on patient functioning.

Spotlight on Heart Failure: A Cardiologist's Perspective

Professor Mark Petrie in this video answers the question: Is there such a thing as “stable heart failure patients”?

Role of Primary Care in Heart Failure

SGLT-2i and HFrEF

Prof Sindone speaks about the role of the GP in optimising to GDMT with an SGLT-2i, regardless of T2D status.

Importance of Early Referral in HF by Primary Care 

General Practitioner Dr Naresh Kanumilli discusses the importance of early referral for patients with heart failure early and the role primary care plays in this process.

Early treatment for Chronic Heart Failure patients

General Practitioner Dr Gary Deed discusses the importance of treating patients with heart failure early and the role primary care plays in this process.

Evidence for Dapagliflozin in Heart Failure

DAPA-HF + DELIVER Data

Hear from Prof. Andrew Sindone as he unpacks the pooled analysis of DAPA-HF and DELIVER trials. Gain key insights into dapagliflozin’s role in heart failure across all LVEF ranges.

Treating Patients with Heart Failure with Prof. Zaheer Yousef

Prof. Zaheer Yousef shares a quick (~1 min) commentary on treating patients with reduced and preserved ejection fraction with results from the DAPA-HF and DELIVER trials.

Research Review: DAPA-HF and DELIVER Study Review

Quick look at the combined trial data exploring dapagliflozin use across the entire ejection fraction range in heart failure care.

DAPA-HF Clinical Trial Summary

A concise overview of the DAPA HF study design, patient profile, primary endpoints, and the CKD related PBS listing details for dapagliflozin.

DELIVER Clinical Trial Summary

A brief snapshot of the DELIVER trial’s design and key endpoints in HF with mildly reduced/preserved EF, plus the most recent PBS listing context for dapagliflozin.

Other Topics of Interest

Microbiome and Gut Health in CVRM

Prof. Emad El Omar (Editor in Chief of Gut, University of NSW) explores the crucial role of gut health in CVRM patients.

GMRx2 and QUADRO Trials

Single-pill therapies show promise for resistant hypertension.

Patient Resources

Access helpful resources to share with your patients.

Heart Health Symptom Tracker

HF & Me: Booklet 1

You might also be interested in

Renal Hub

Explore resources for the diagnosis and management of chronic kidney disease.

Metabolic Hub

Explore resources for the diagnosis and management of type 2 diabetes.

Forxiga®

Learn more about Forxiga® in heart failure here.

Abbreviations: HF, heart failure; GDMT, guidelines-directed medical therapy.

Want to know more?

If you have any questions or would like to be kept updated on new training
resources please subscribe to our email newsletter or reach out below.

 

Loading......